InvestSMART

CSL Limited (ASX: CSL) - Announcements

- Current share price for CSL : $200.730

ASX company news and announcements for CSL Limited (CSL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All CSL Limited (CSL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than CSL Limited (CSL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for CSL Limited (CSL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$96,327 Update - Notification of buy-back - CSL 2 Nov 2026 8:07AM $200.730 $200.730 fallen by 0%
$96,327 Update - Notification of buy-back - CSL 30 Oct 2026 8:12AM $197.500 $200.730 risen by 1.64%
$96,327 CSL 2026 AGM Results of Meeting 27 Oct 2026 1:57PM $194.620 $200.730 risen by 3.14%
$96,327 CSL Limited Annual General Meeting 2026 27 Oct 2026 9:47AM $195.140 $200.730 risen by 2.86%
$96,327 Brian McNamee to retire Gordon Naylor appointed next Chair 26 Oct 2026 8:40AM $196.700 $200.730 risen by 2.05%
$96,327 CSL to Defend Class Action 22 Oct 2026 9:04AM $196.080 $200.730 risen by 2.37%
$96,327 Appointment of New CEO 21 Oct 2026 4:37PM $196.080 $200.730 risen by 2.37%
$96,327 Update on U.S. Plasma Collection Network 8 Oct 2026 6:44PM $181.460 $200.730 risen by 10.62%
$96,327 CSL prices US$1.5 billion in Corporate Bonds 7 Oct 2026 9:24AM $178.680 $200.730 risen by 12.34%
$96,327 CSL enters exclusive agreement with Alentis Therapeutics 5 Oct 2026 8:22AM $175.350 $200.730 risen by 14.47%
$96,327 Update - Notification of buy-back - CSL 24 Sep 2026 8:22AM $179.240 $200.730 risen by 11.99%
$96,327 Update - Notification of buy-back - CSL 23 Sep 2026 8:17AM $180.720 $200.730 risen by 11.07%
$96,327 Update - Notification of buy-back - CSL 22 Sep 2026 8:22AM $178.300 $200.730 risen by 12.58%
$96,327 Update - Notification of buy-back - CSL 18 Sep 2026 8:21AM $177.560 $200.730 risen by 13.05%
$96,327 Update - Notification of buy-back - CSL 17 Sep 2026 8:21AM $174.410 $200.730 risen by 15.09%
$96,327 Notice of Meeting and Shareholder Pack 2026 17 Sep 2026 8:19AM $174.410 $200.730 risen by 15.09%
$96,327 Update - Notification of buy-back - CSL 16 Sep 2026 8:24AM $174.260 $200.730 risen by 15.19%
$96,327 Update - Notification of buy-back - CSL 15 Sep 2026 8:21AM $171.570 $200.730 risen by 17%
$96,327 Update - Dividend/Distribution - CSL 14 Sep 2026 8:22AM $167.100 $200.730 risen by 20.13%
$96,327 Update - Notification of buy-back - CSL 8 Sep 2026 4:31PM $174.800 $200.730 risen by 14.83%
$96,327 Application for quotation of securities - CSL 8 Sep 2026 4:30PM $174.800 $200.730 risen by 14.83%
$96,327 Notification regarding unquoted securities - CSL 8 Sep 2026 4:26PM $174.800 $200.730 risen by 14.83%
$96,327 Notification of cessation of securities - CSL 7 Sep 2026 4:42PM $173.180 $200.730 risen by 15.91%
$96,327 Notification of cessation of securities - CSL 4 Sep 2026 8:20AM $175.500 $200.730 risen by 14.38%
$96,327 Application for quotation of securities - CSL 4 Sep 2026 8:20AM $175.500 $200.730 risen by 14.38%

1 - 25 of 1199 results

Page 1 of 48

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.